volume 58 issue 5 pages 534-543

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

Claire Michel 1
Marie Robin 2
Stephane Morisset 3
D. Blaise 4
Johan Maertens 5
Patrice Chevalier 6
Cristina Castilla-Llorente 7
E. Forcade 8
Patrice Ceballos 9
Ibrahim Yakoub-Agha 10
Xavier Poire 11
Martin Carre 12
Jacques-Olivier Bay 13
Yves Beguin 14
M. Loschi 15
Anne Huynh 16
Gaëlle Guillerm 17
Sylvie François 18
Jean-Baptiste Mear 19
R. Dulery 20
Felipe Suarez 21
Karin Bilger 22
J. Cornillon 23
Y Chalandon 24
Natacha Maillard 25
Hélène Labussière-Wallet 26
Amandine Charbonnier 27
Pascal Turlure 28
Ana Berceanu 29
Sylvain Chantepie 30
Sébastien Maury 31
Ali Bazarbachi 32
Anne-Lise Menard 33
Stephanie Nguyen-Quoc 34
Marie-Thérèse Rubio 1
Maud D’Aveni 1
2
 
Hematology department, Hôpital Saint-Louis, Paris, France
3
 
Biostatistics Consultant, Pérouges, France
4
 
Hematology Department, Institut Paoli Calmette, Marseille, France
8
 
Hematology department, Hôpital Haut-Levêque, Bordeaux, France
9
 
Hematology department, Hôpital Saint Eloi, Montpellier, France
11
 
Section of Hematology, Cliniques Universitaires St-Luc, Brussels, Belgium
12
 
Hematology department, Hôpital Michallon, Grenoble, France
14
 
Hematology department, University hospital of Liège, Liège, Belgium
15
 
Hematology department Hôpital l’Archet, Nice, France
20
 
Hematology department, Hôpital Saint-Antoine, Paris, France
28
 
Hematology department, Hôpital Dupuytren, Limoges, France
31
 
Hematology Department, Hôpital Henri Mondor, Créteil, France
32
 
Hematology department, American university of Beyrouth, Beyrouth, Lebanon
33
 
Hematology department Centre Henri Bequerel, Rouen, France
34
 
Hematology department, Hôpital La Pitié Salpêtrière, Paris, France
Publication typeJournal Article
Publication date2023-02-11
scimago Q1
wos Q1
SJR1.709
CiteScore8.4
Impact factor5.2
ISSN02683369, 14765365
Hematology
Transplantation
Abstract

Allogeneic hematopoietic stem cell transplantation remains the best curative option for higher-risk myelodysplastic syndrome. The presence of monosomal karyotype and/or complex karyotype abnormalities predicts inferior survival after allo-SCT in MDS patients. Haploidentical allo-SCT has been increasingly used in acute leukemia (AL) and has similar results as using HLA-matched donors, but data on higher-risk MDS is sparse. We compared outcomes in 266 patients with higher-risk MDS after HLA-matched sibling donor (MSD, n = 79), HLA-matched unrelated donor (MUD, n = 139) and HLA haploidentical donor (HID, n = 48) from 2010 to 2019. Median donor age differed between the three groups (p < 0.001). The overall survival was significantly different between the three groups with a better OS observed in the MUD group (p = 0.014). This observation could be explained by a higher progression-free survival with MUD (p = 0.014). The cumulative incidence of grade 2–4 acute GvHD was significantly higher in the HID group (p = 0.051). However, in multivariable analysis, patients transplanted using an HID had comparable mortality to patients transplanted using a MUD (subdistribution hazard ratio [sHR]: 0.58 [0.32–1.07]; p = 0.080) and a MSD ([sHR]: 0.56 [0.28–1.11]; p = 0.094). MUD do not remain a significant positive predictor of survival, suggesting that beyond the donor-recipient HLA matching, the donor age might impact recipient outcome.

Found 
Found 

Top-30

Journals

1
2
Leukemia and Lymphoma
2 publications, 12.5%
British Journal of Haematology
1 publication, 6.25%
Transplantation and Cellular Therapy
1 publication, 6.25%
American Journal of Hematology
1 publication, 6.25%
Transplant Immunology
1 publication, 6.25%
Blood Reviews
1 publication, 6.25%
Bulletin du Cancer
1 publication, 6.25%
Cell Transplantation
1 publication, 6.25%
Blood Research
1 publication, 6.25%
Blood
1 publication, 6.25%
International Journal of Cancer
1 publication, 6.25%
Stem Cell Reviews and Reports
1 publication, 6.25%
Hematology
1 publication, 6.25%
1
2

Publishers

1
2
3
4
Elsevier
4 publications, 25%
Wiley
3 publications, 18.75%
Taylor & Francis
3 publications, 18.75%
Springer Nature
2 publications, 12.5%
Research Square Platform LLC
1 publication, 6.25%
SAGE
1 publication, 6.25%
American Society of Hematology
1 publication, 6.25%
1
2
3
4
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
16
Share
Cite this
GOST |
Cite this
GOST Copy
Michel C. et al. Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS // Bone Marrow Transplantation. 2023. Vol. 58. No. 5. pp. 534-543.
GOST all authors (up to 50) Copy
Michel C., Robin M., Morisset S., Blaise D., Maertens J., Chevalier P., Castilla-Llorente C., Forcade E., Ceballos P., Yakoub-Agha I., Poire X., Carre M., Bay J., Beguin Y., Loschi M., Huynh A., Guillerm G., François S., Mear J., Dulery R., Suarez F., Bilger K., Cornillon J., Chalandon Y., Maillard N., Labussière-Wallet H., Charbonnier A., Turlure P., Berceanu A., Chantepie S., Maury S., Bazarbachi A., Menard A., Nguyen-Quoc S., Rubio M., D’Aveni M. Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS // Bone Marrow Transplantation. 2023. Vol. 58. No. 5. pp. 534-543.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41409-023-01931-7
UR - https://doi.org/10.1038/s41409-023-01931-7
TI - Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
T2 - Bone Marrow Transplantation
AU - Michel, Claire
AU - Robin, Marie
AU - Morisset, Stephane
AU - Blaise, D.
AU - Maertens, Johan
AU - Chevalier, Patrice
AU - Castilla-Llorente, Cristina
AU - Forcade, E.
AU - Ceballos, Patrice
AU - Yakoub-Agha, Ibrahim
AU - Poire, Xavier
AU - Carre, Martin
AU - Bay, Jacques-Olivier
AU - Beguin, Yves
AU - Loschi, M.
AU - Huynh, Anne
AU - Guillerm, Gaëlle
AU - François, Sylvie
AU - Mear, Jean-Baptiste
AU - Dulery, R.
AU - Suarez, Felipe
AU - Bilger, Karin
AU - Cornillon, J.
AU - Chalandon, Y
AU - Maillard, Natacha
AU - Labussière-Wallet, Hélène
AU - Charbonnier, Amandine
AU - Turlure, Pascal
AU - Berceanu, Ana
AU - Chantepie, Sylvain
AU - Maury, Sébastien
AU - Bazarbachi, Ali
AU - Menard, Anne-Lise
AU - Nguyen-Quoc, Stephanie
AU - Rubio, Marie-Thérèse
AU - D’Aveni, Maud
PY - 2023
DA - 2023/02/11
PB - Springer Nature
SP - 534-543
IS - 5
VL - 58
PMID - 36774430
SN - 0268-3369
SN - 1476-5365
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Michel,
author = {Claire Michel and Marie Robin and Stephane Morisset and D. Blaise and Johan Maertens and Patrice Chevalier and Cristina Castilla-Llorente and E. Forcade and Patrice Ceballos and Ibrahim Yakoub-Agha and Xavier Poire and Martin Carre and Jacques-Olivier Bay and Yves Beguin and M. Loschi and Anne Huynh and Gaëlle Guillerm and Sylvie François and Jean-Baptiste Mear and R. Dulery and Felipe Suarez and Karin Bilger and J. Cornillon and Y Chalandon and Natacha Maillard and Hélène Labussière-Wallet and Amandine Charbonnier and Pascal Turlure and Ana Berceanu and Sylvain Chantepie and Sébastien Maury and Ali Bazarbachi and Anne-Lise Menard and Stephanie Nguyen-Quoc and Marie-Thérèse Rubio and Maud D’Aveni},
title = {Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS},
journal = {Bone Marrow Transplantation},
year = {2023},
volume = {58},
publisher = {Springer Nature},
month = {feb},
url = {https://doi.org/10.1038/s41409-023-01931-7},
number = {5},
pages = {534--543},
doi = {10.1038/s41409-023-01931-7}
}
MLA
Cite this
MLA Copy
Michel, Claire, et al. “Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS.” Bone Marrow Transplantation, vol. 58, no. 5, Feb. 2023, pp. 534-543. https://doi.org/10.1038/s41409-023-01931-7.
Profiles